Answer to Question 1
B
Feedback:
Daclizumab is specific to interleukin-2 receptor sites on activated T lymphocytes; it reacts with those sites and blocks cellular response to allograft transplants. Alemtuzumab is an antibody specific for lymphocyte receptor sites used to treat chronic lymphocytic leukemia patients who have been treated with alkylating agents and have been failed by fludarabine therapy. Erlotinib is effective against specific malignant receptor sites. Omalizumab is an antibody to immunoglobulin E, an important factor in allergic reactions.
Answer to Question 2
A
Feedback:
The next phase, called the S phase, involves the actual synthesis of DNA, which is an energy-consuming activity. The cell remains in this phase until the amount of cellular DNA has doubled. The G0 phase is considered the resting phase of the cell cycle. The M phase is when cell replication occurs. The G2 phase is when the cell produces all substances it needs to replicate.
Different gene orders give different double recombinants
The medical assistant escorts the patient into the examination room.
Example of a patient’s ledger in practice management software.
Assisting a falling patient.
Risk assessment codes for an HIV-infected patient.